NEW YORK–(BUSINESS WIRE)–DFP Healthcare Acquisitions Corp. (the “Company”) announced today that it closed its initial public offering of 23,000,000 units at a price of $10.00 per unit, including 3,000,000 units issued pursuant to the exercise by the underwriters of their...

NEW YORK–(BUSINESS WIRE)–DFP Healthcare Acquisitions Corp. (the “Company”) announced today the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade...

LOS ANGELES–(BUSINESS WIRE)–Flying Eagle Acquisition Corp. (the “Company”), the sixth public acquisition vehicle led by Harry Sloan and founding investor Jeff Sagansky, today announced the closing of its initial public offering of 69,000,000 units, including 9,000,000 units issued pursuant to...

Successful IPO Underscores BGV’s Value Creation Capabilities from Early Stage to IPO PALO ALTO, Calif.–(BUSINESS WIRE)–BGV, an early-stage venture capital firm with deep Silicon Valley roots and an exclusive focus on global enterprise 4.0 startups, today announced the IPO of...

LOS ANGELES–(BUSINESS WIRE)–Flying Eagle Acquisition Corp. (the “Company”), the sixth public acquisition vehicle led by Harry Sloan and founding investor Jeff Sagansky, today announced the pricing of its initial public offering of 60,000,000 units, upsized from 50,000,000 units, at a...

RICHMOND, Va.–(BUSINESS WIRE)–Medalist Diversified REIT, Inc. (Nasdaq: MDRR) (the “Company”), a Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in the Mid-Atlantic and Southeast regions, announced today the pricing of its underwritten...

SAN MATEO, Calif.–(BUSINESS WIRE)–Sumeru Equity Partners (SEP), a growth-focused technology investment firm, today announced the initial public offering (IPO) of Locaweb Servicos de Internet SA (BVMF:LWSA3), a portfolio company of SEP’s predecessor fund, Silver Lake Sumeru, on Bovespa, the Sao...

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics Inc. (Nasdaq:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the closing of its initial public offering of 12,176,471 shares of common stock, including the exercise in full by the underwriters of...

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the pricing of its initial public offering of 10,588,236 shares of common stock at a public offering price of $17.00 per...

NEW YORK–(BUSINESS WIRE)–Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, today announced the closing of its initial public offering of 13,664,704 shares of common stock...